当前位置： SCI文献检索 > Brachytherapy期刊下所有文献 > Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer.

Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer.

Abstract：

PURPOSE:To describe the use of dual source strength implants for focal low-dose-rate brachytherapy. METHODS AND MATERIALS:An interneedle dual source strength planning strategy is described for focal low-dose-rate brachytherapy of the prostate. The implanted treatment plans were designed using peripheral (except near the rectum) needles loaded with high strength (0.9 U) sources and central needles loaded with low strength (0.4 U) sources ("interneedle" dual strength planning). This approach has been applied for focally treating 3 patients. In this article, we compare the characteristics and robustness to source motion of interneedle dual strength planning with four alternative planning strategies (single strength high, low, and intermediate, and intraneedle dual strength) on 50 simulated cases. RESULTS:Interneedle dual source strength planning results in greater robustness to source motion and overall lower seed and needle density compared to the standard low source strength planning currently used in our centre. This planning approach is also significantly superior to single strength high, single strength intermediate and intraneedle dual strength planning strategies in terms of high dose to the urethral avoidance structure. CONCLUSIONS:The use of interneedle dual source strength treatment plans for focal low-dose-rate brachytherapy is possibly the practical solution for limiting the density of sources required to deliver the prescribed dose while limiting proximity of high strength sources to organs at risk.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Mahdavi SS,Spadinger IT,Chng NT,Morris WJ

doi

10.1016/j.brachy.2016.04.388

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

642-9

issue

5

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(16)30432-9

journal_volume

15

pub_type

杂志文章

相关文献

Brachytherapy文献大全
  • Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.

    abstract：PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We...

    journal_title：Brachytherapy

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.brachy.2013.04.008

    authors： Haworth A,Williams S,Reynolds H,Waterhouse D,Duchesne GM,Bucci J,Joseph D,Bydder S,Ebert M

    更新日期：2013-11-01 00:00:00

  • Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk.

    abstract：PURPOSE:To assess the toxicity and efficacy of salvage wide resection (SWR) with intraoperative electron beam radiation therapy (IOERT) or perioperative high-dose-rate brachytherapy (PHDRB) in previously unirradiated patients (PUP) vs. previously irradiated patients (PIP) with isolated local recurrence of soft tissue s...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2014.09.003

    authors： Cambeiro M,Aristu JJ,Moreno Jimenez M,Arbea L,Ramos L,San Julian M,Azinovic I,Calvo FA,Martínez-Monge R

    更新日期：2015-01-01 00:00:00

  • Income generated by women treated with magnetic resonance imaging-based brachytherapy: A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting.

    abstract：PURPOSE:To estimate the difference in income generated if all women presenting in our institute over a 5-year period were treated with MRI-based image-guided brachytherapy (MR-IGBT) instead of conventional radiograph-based brachytherapy (CR-BT). METHODS AND MATERIALS:Outcome data from 463 patients (94 treated with MR-...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.05.003

    authors： Chakraborty S,Mahantshetty U,Chopra S,Lewis S,Hande V,Gudi S,Krishnatry R,Engineer R,Shrivastava SK

    更新日期：2017-01-01 00:00:00

  • Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.

    abstract：PURPOSE:To improve efficiency, convenience, and cost, a prospective phase II trial was initiated to evaluate accelerated partial breast irradiation delivered with noninvasive image-guided breast brachytherapy (NIBB) via five once-daily fractions. METHODS AND MATERIALS:Women ≥50 years old with early-stage breast cancer...

    journal_title：Brachytherapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.brachy.2018.05.006

    authors： Hepel JT,Yashar C,Leonard KL,Einck JP,Sha S,DiPetrillo T,Wiggins D,Graves TA,Edmonson D,Brown University Oncology Research Group.,Wazer DE

    更新日期：2018-01-01 00:00:00

  • GERICO-03 phase II trial of accelerated and partial breast irradiation in elderly women: feasibility, reproducibility, and impact on functional status.

    abstract：PURPOSE:To analyze the feasibility, reproducibility, and impact on functional status of postoperative accelerated and partial breast irradiation (APBI) using interstitial high-dose rate-brachytherapy in women older than 70 years. METHODS AND MATERIALS:From July 2004 to April 2008, 46 patients were screened for enrollm...

    journal_title：Brachytherapy

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.brachy.2012.06.004

    authors： Hannoun-Levi JM,Gourgou-Bourgade S,Belkacemi Y,Chara-Bruneau C,Hennequin C,Quetin P,Orsini C,Brain E,Marsiglia H

    更新日期：2013-07-01 00:00:00

  • Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.

    abstract：PURPOSE:To evaluate the results of high-dose-rate (HDR)-interstitial brachytherapy (ISBT) in oral tongue carcinomas. METHODS AND MATERIALS:Between September 1999 and August 2007, 50 patients were treated for oral tongue carcinoma with HDR-ISBT. The patient's mean age was 58 years. Forty-two patients were in T1-2 stage...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2009.10.003

    authors： Guinot JL,Santos M,Tortajada MI,Carrascosa M,Estellés E,Vendrell JB,Muelas R,Chust ML,Mengual JL,Arribas L

    更新日期：2010-07-01 00:00:00

  • MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.

    abstract：PURPOSE:To establish dose-volume effect correlations for late small bowel (SB) toxicities in patients treated for locally advanced cervical cancer with concomitant chemoradiation followed by pulsed-dose rate MRI-guided adaptive brachytherapy. METHODS AND MATERIALS:Patients treated with curative intent and followed pro...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.04.004

    authors： Petit C,Dumas I,Chargari C,Martinetti F,Maroun P,Doyeux K,Tailleur A,Haie-Meder C,Mazeron R

    更新日期：2016-07-01 00:00:00

  • Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy.

    abstract：OBJECTIVE:The aim of the study is to compare the results of the combined external beam radiotherapy (EBRT) with iodine-125 seed brachytherapy vs. brachytherapy alone for prostate cancer treatment in patients with intermediate and high risk of disease recurrence. METHODS AND MATERIALS:Ninety-six patients were treated f...

    journal_title：Brachytherapy

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.brachy.2009.07.011

    authors： da Silva Franca CA,Vieira SL,Carvalho AC,Bernabé AJ,Penna AB

    更新日期：2010-10-01 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract：PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.01.007

    authors： Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期：2020-01-01 00:00:00

  • Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy.

    abstract：PURPOSE:The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS:Monte Carlo...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2011.11.005

    authors： Vijande J,Ballester F,Ouhib Z,Granero D,Pujades-Claumarchirant MC,Perez-Calatayud J

    更新日期：2012-11-01 00:00:00

  • Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe.

    abstract：PURPOSE:Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and urinary toxicity of a minimal photovaporization (mPVP) before implantation. MATERIALS AND MET...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.08.003

    authors： Peigne C,Fournier G,Dissaux G,Delage F,Coquet JB,Boussion N,Goasduff G,Malhaire JP,Pradier O,Schick U,Valeri A

    更新日期：2021-01-01 00:00:00

  • Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.

    abstract：BACKGROUND:This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an adjunct to salvage surgery in primary advanced or recurrent gynecologic cancer. METHODS:Twenty-five patients with either locally advanced (n = 4) or recurrent (n = 21) gynecologic cancer suitab...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2006.07.001

    authors： Martínez-Monge R,Jurado M,Cambeiro M,Valero J,Villafranca E,Alcázar JL

    更新日期：2006-10-01 00:00:00

  • Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy.

    abstract：PURPOSE:Certain subsets of patients have an increased risk of all-cause mortality when androgen deprivation therapy (ADT) is used with definitive radiotherapy. We evaluated the relationship between pretreatment serum testosterone, age, and comorbidities on survival after prostate brachytherapy in men treated with and w...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2009.06.008

    authors： Taira AV,Merrick GS,Galbreath RW,Butler WM,Wallner KE

    更新日期：2010-01-01 00:00:00

  • Single-energy metal artifact reduction in postimplant computed tomography for I-125 prostate brachytherapy: Impact on seed identification.

    abstract：PURPOSE:To evaluate the effectiveness of the single-energy metal artifact reduction (SEMAR) technique for improving the accuracy of I-125 seed identification in postimplant computed tomography (CT) after prostate brachytherapy. METHODS AND MATERIALS:Postimplant CT images of 40 patients treated with I-125 prostate brac...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.07.006

    authors： Shiraishi Y,Yamada Y,Tanaka T,Eriguchi T,Nishimura S,Yoshida K,Hanada T,Ohashi T,Shigematsu N,Jinzaki M

    更新日期：2016-01-01 00:00:00

  • Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.

    abstract：PURPOSE:To analyze the effect of tungsten shields present in a Fletcher-Suit-Delclos ovoid by comparing the dose distribution computed by a treatment planning system (TPS) to the delivered dose distribution measured by radiochromic film dosimetry. METHODS AND MATERIALS:Gafchromic/EBT films were carefully wrapped aroun...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2010.08.008

    authors： Hira M,Podgorsak MB,Jaggernauth W,Malhotra HK

    更新日期：2011-05-01 00:00:00

  • An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.

    abstract：PURPOSE:To compare dose-volume histogram variables for the internal and external urinary sphincters (IUS/EUS) with urinary quality of life after prostate brachytherapy. METHODS AND MATERIALS:Subjects were 42 consecutive men from a prospective study of brachytherapy as monotherapy with (125)I for intermediate-risk loca...

    journal_title：Brachytherapy

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.brachy.2012.10.006

    authors： Register SP,Kudchadker RJ,Levy LB,Swanson DA,Pugh TJ,Bruno TL,Frank SJ

    更新日期：2013-05-01 00:00:00

  • Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with (125)I seeds.

    abstract：OBJECTIVES:To determine the relationship between dosimetric parameters obtained on postimplantation Day 0 and biochemical relapse-free survival (bRFS) in patients treated with (125)I transperineal interstitial permanent prostate brachytherapy (TIPPB). METHODS:Two-hundred twenty men with low-risk (n=155, 70.4%), low-vo...

    journal_title：Brachytherapy

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.brachy.2009.04.005

    authors： Garrán C,Ciérvide R,Cambeiro M,Moreno-Jiménez M,Ramos LI,Martínez-Monge R

    更新日期：2010-01-01 00:00:00

  • Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.

    abstract：PURPOSE:The treatment of locally advanced cervical cancer with definitive chemoradiation (CRT) is associated with vaginal toxicity and altered sexual satisfaction. This prospective study assessed patient-reported sexual adjustment, vaginal dosimetry, and physician-reported vaginal toxicity in patients with cervical can...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2018.09.005

    authors： Conway JL,Gerber R,Han K,Jiang H,Xie J,Beiki-Ardakani A,Fyles A,Milosevic M,Williamson D,Croke J

    更新日期：2019-01-01 00:00:00

  • Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.

    abstract：PURPOSE:The aim of this study was to compare the organ-at-risk doses to the rectum and the bladder in postoperative endometrial cancer patients who receive high-dose-rate vaginal brachytherapy (HDR-VB), when using three different methods of treatment planning: (Workflow A) individualized treatment planning before every...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.11.008

    authors： Gruhl JD,Zheng D,Longo JL,Enke C,Wahl AO

    更新日期：2017-01-01 00:00:00

  • High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.

    abstract：PURPOSE:Treatment options are limited for patients with localized prostate cancer and a prior history of abdominoperineal resection (APR) and pelvic irradiation. We have previously reported on the successful utility of high-dose-rate (HDR) brachytherapy salvage for prostate cancer failing definitive external beam radia...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2009.02.004

    authors： Jabbari S,Hsu IC,Kawakami J,Weinberg VK,Speight JL,Gottschalk AR,Roach M 3rd,Shinohara K

    更新日期：2009-10-01 00:00:00

  • Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.

    abstract：PURPOSE:Marriage has been associated with enhanced survival among cancer patients, but conflicting correlations have been suggested in cervical cancer. We assessed the impact of marital status on receipt of brachytherapy and survival in women with locally advanced cervical cancer. METHODS AND MATERIALS:Three thousand,...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.04.273

    authors： Huynh-Le MP,Klapheke A,Cress R,Mell LK,Yashar CM,Einck JP,Mundt AJ,Mayadev JS

    更新日期：2019-01-01 00:00:00

  • Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: alternative to aggressive surgery.

    abstract：:A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(03)00098-9

    authors： Martínez-Monge R,Pérez-Ochoa A,San Julián M,Aquerreta D,Sierrasesúmaga L

    更新日期：2003-01-01 00:00:00

  • American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy.

    abstract：PURPOSE:To present recommendations for the use of brachytherapy (BT) in patients with soft tissue sarcoma (STS). METHODS:A group of practitioners with expertise and experience in sarcoma BT formulated recommendations for BT in STS based on clinical experience and literature review. RESULTS:The indications for adjuvan...

    journal_title：Brachytherapy

    pub_type： 杂志文章,评审

    doi：10.1016/j.brachy.2012.12.002

    authors： Holloway CL,Delaney TF,Alektiar KM,Devlin PM,O'Farrell DA,Demanes DJ

    更新日期：2013-05-01 00:00:00

  • Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.

    abstract：PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.09.008

    authors： Simha V,Rai B,Patel FD,Kapoor R,Sharma SC,Singh OA,Singla V,Dhanireddy B,Ghoshal S

    更新日期：2018-01-01 00:00:00

  • Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.

    abstract：PURPOSE:Persistent disease after definitive external beam radiation therapy for head and neck (H&N) malignancies negatively impacts survival. In this series, the effectiveness of low-dose-rate brachytherapy in the management of persistent H&N disease is explored. METHODS:All patients who received brachytherapy for per...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.12.007

    authors： Grimard L,Esche B,Lamothe A,Spaans JN

    更新日期：2009-07-01 00:00:00

  • The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.

    abstract：PURPOSE:Education and training on prostate brachytherapy for radiation oncology and medical physics residents in the United States is inadequate, resulting in fewer competent radiation oncology personnel to perform implants, and is a factor in the subsequent decline of an important, potentially curative cancer treatmen...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.10.001

    authors： Frank SJ,Mourtada F,Crook J,Orio PF,Stock RG,Petereit DG,Rossi PJ,Cox BW,Tang C,Kudchadker RJ,Bruno T,Ma J,Sanders J,Keyes M

    更新日期：2020-01-01 00:00:00

  • Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.

    abstract：OBJECTIVES:To evaluate the interim outcomes of low-dose-rate permanent brachytherapy (PB) combined with short-term androgen deprivation therapy (ADT) in Japanese men with intermediate-risk prostate cancer excluding those with a Gleason score of 4+3. METHODS:The Protocol-intermediate-risk group (Protocol-IRG) was defin...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2014.09.001

    authors： Yamada Y,Masui K,Iwata T,Naitoh Y,Yamada K,Miki T,Okihara K

    更新日期：2015-03-01 00:00:00

  • Improving patient-specific dosimetry for intravascular brachytherapy.

    abstract：PURPOSE:Accurate patient-specific dosimetry in intravascular brachytherapy (IVBT) is generally difficult due to the extremely high-dose gradient, complexity of treatment device, and patient-specific geometry (e.g., calcification, stent, curvature, movement of target). The purpose of this study is to analyze quantitativ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2005.07.004

    authors： Li XA,O'Neill M,Suntharalingam M

    更新日期：2005-01-01 00:00:00

  • Is stereotactic CyberKnife radiotherapy or multicatheter HDR brachytherapy the better option dosimetrically for accelerated partial breast irradiation?

    abstract：OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.10.003

    authors： Fröhlich G,Mészáros N,Smanykó V,Stelczer G,Herein A,Polgár C,Major T

    更新日期：2020-11-18 00:00:00

  • First clinical implementation of GammaTile permanent brain implants after FDA clearance.

    abstract：PURPOSE:GammaTile cesium-131 (131Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinic...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.12.005

    authors： Ferreira C,Sterling D,Reynolds M,Dusenbery K,Chen C,Alaei P

    更新日期：2021-01-21 00:00:00